Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.
Clinical trial NCT03212131 · COMPLETED
Trial details
- NCT number
- NCT03212131
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2018-03-08
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.